| Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy (NCT00890747) | National Cancer Institute (NCI) | 2009-08-01 |
| Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma (NCT00918333) | Mayo Clinic | 2009-06-01 |
| Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders (NCT00856388) | Roswell Park Cancer Institute | 2009-01-14 |
| Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma (NCT00693433) | National Cancer Institute (NCI) | 2008-12-01 |
| Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications (NCT00799461) | Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | 2008-08-01 |
| Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00719901) | National Cancer Institute (NCI) | 2008-07-01 |
| Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant (NCT00619684) | Fred Hutchinson Cancer Center | 2008-02-01 |
| A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma (NCT00912899) | Cougar Biotechnology, Inc. | 2007-12-01 |
| Sunitinib in Treating Patients With Relapsed Multiple Myeloma (NCT00514137) | National Cancer Institute (NCI) | 2007-09-01 |
| Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma (NCT00398515) | National Cancer Institute (NCI) | 2007-03-01 |
| High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00536601) | Roswell Park Cancer Institute | 2006-06-29 |
| A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies (NCT00343798) | Fred Hutchinson Cancer Center | 2006-04-01 |
| Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00253578) | National Cancer Institute (NCI) | 2006-03-01 |
| Sorafenib and Bortezomib in Treating Patients With Advanced Cancer (NCT00303797) | National Cancer Institute (NCI) | 2005-12-01 |
| Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma (NCT00112723) | National Cancer Institute (NCI) | 2005-12-01 |
| Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00310024) | National Cancer Institute (NCI) | 2005-11-01 |
| Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma (NCT00243035) | National Cancer Institute (NCI) | 2005-08-01 |
| Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma (NCT00217438) | Fred Hutchinson Cancer Center | 2005-07-01 |
| Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma (NCT00124605) | National Cancer Institute (NCI) | 2005-04-01 |
| Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00118352) | Fred Hutchinson Cancer Center | 2005-03-01 |
| Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant (NCT00114101) | National Cancer Institute (NCI) | 2004-12-15 |
| Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma (NCT00112827) | City of Hope Medical Center | 2004-11-01 |
| Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function (NCT00118170) | National Cancer Institute (NCI) | 2004-10-01 |
| Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma (NCT00306813) | University of Wuerzburg | 2004-09-01 |
| Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma (NCT00153933) | Dana-Farber Cancer Institute | 2004-08-01 |
| Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer (NCT00089011) | Fred Hutchinson Cancer Center | 2004-04-01 |
| Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00079456) | National Cancer Institute (NCI) | 2004-02-01 |
| Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant (NCT00078858) | Fred Hutchinson Cancer Center | 2003-09-01 |
| Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant (NCT00182663) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer (NCT00060372) | National Cancer Institute (NCI) | 2003-04-01 |
| Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction (NCT00054483) | National Cancer Institute (NCI) | 2003-01-01 |
| Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT00054353) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00047203) | National Cancer Institute (NCI) | 2002-09-01 |
| Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer (NCT00049504) | Fred Hutchinson Cancer Center | 2002-01-01 |
| 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors (NCT00028821) | National Cancer Institute (NCI) | 2002-01-01 |
| Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction (NCT00025415) | National Cancer Institute (NCI) | 2001-08-01 |
| Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies (NCT00014235) | Fred Hutchinson Cancer Center | 2000-12-01 |
| Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma (NCT00006244) | Fred Hutchinson Cancer Center | 2000-02-01 |
| Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer (NCT00005799) | Fred Hutchinson Cancer Center | 1999-11-01 |
| Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma (NCT00003954) | Fred Hutchinson Cancer Center | 1999-03-01 |
| Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma (NCT00003196) | Fred Hutchinson Cancer Center | 1997-09-01 |
| Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation (NCT00002787) | Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | 1996-03-01 |
| High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma (NCT01177371) | Case Comprehensive Cancer Center | 1988-03-01 |
| Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT00995059) | Mayo Clinic | |
| GO-203-2C + Bortezomib For Relapsed Or Refractory MM (NCT02658396) | Dana-Farber Cancer Institute | |